Abiopharma

Clinical trial NCT04410796 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01

Clinical trial NCT06465199 updates: 1. start date: 2026-04-28 → 2026-05-13 2. completion date: 2035-02-01 → 2035-05-01 3. primary completion date: 2033-02-01 → 2033-05-01

Clinical trial NCT04780009 updates: 1. completion date: 2026-06-01 → 2027-08-01 2. primary completion date: 2026-06-01 → 2027-08-01

Clinical trial NCT06520072 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2024-11-19 3. primary completion date: 2025-12-01 → 2024-11-19 4. enrollment: 1200 → 224 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05111925 updates: 1. completion date: 2025-05-31 → 2028-05-31 2. primary completion date: 2025-05-31 → 2027-05-31

Clinical trial NCT07587697 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 30 → 15 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07586618 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-01

Coupang Jumps to No. 132 on Fortune 500® as the Company Scales AI-Driven Global Commerce

C.H. Robinson Launches Worlds First AI Technology That Continually Assesses, Improves and Operates Global Supply Chains

ModelFront Announces Outcome-Based Pricing